• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Public Health. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality

tetano

Editor, Senior Moderator
Front Public Health. 2020 Apr 29;8:152. doi: 10.3389/fpubh.2020.00152. eCollection 2020.
Gender Differences in Patients With COVID-19: Focus on Severity and Mortality.


Jin JM[SUP]1,[/SUP][SUP]2[/SUP], Bai P[SUP]1,[/SUP][SUP]2[/SUP], He W[SUP]3[/SUP], Wu F[SUP]2[/SUP], Liu XF[SUP]1[/SUP], Han DM[SUP]4[/SUP], Liu S[SUP]2[/SUP], Yang JK[SUP]5[/SUP].

Author information




Abstract

Objective: The recent outbreak of Novel Coronavirus Disease (COVID-19) is reminiscent of the SARS outbreak in 2003. We aim to compare the severity and mortality between male and female patients with COVID-19 or SARS. Study Design and Setting: We extracted the data from: (1) a case series of 43 hospitalized patients we treated, (2) a public data set of the first 37 cases of patients who died of COVID-19 and 1,019 patients who survived in China, and (3) data of 524 patients with SARS, including 139 deaths, from Beijing in early 2003. Results: Older age and a high number of comorbidities were associated with higher severity and mortality in patients with both COVID-19 and SARS. Age was comparable between men and women in all data sets. In the case series, however, men's cases tended to be more serious than women's (P = 0.035). In the public data set, the number of men who died from COVID-19 is 2.4 times that of women (70.3 vs. 29.7%, P = 0.016). In SARS patients, the gender role in mortality was also observed. The percentage of males were higher in the deceased group than in the survived group (P = 0.015). Conclusion: While men and women have the same prevalence, men with COVID-19 are more at risk for worse outcomes and death, independent of age.
Copyright ? 2020 Jin, Bai, He, Wu, Liu, Han, Liu and Yang.



KEYWORDS:

COVID-19; SARS; SARS-CoV-2; female; gender; male; morbidity; mortality


PMID:32411652PMCID:PMC7201103DOI:10.3389/fpubh.2020.00152
 
Back
Top Bottom